Elite Pharmaceuticals Inc (ELTP)

[kayak_wench]

Your trying to compare owning the opioids in 2019 to 2024. Their were lawsuits being brought by the federal, state, and local governments then that were pushing companies into bankruptcy. The risk of bringing opioids to market in that environment was substantial.
In 2019 we also didn't have the long-term revenue and cash we do now. Our gross profit was at best one million versus $8 million now.

No one here cares about the vigabartrin (which Nasrat sold and will only manufacture for a few years because it didn't fit into our drug portfolio) or the Mikah generics. None of these drugs are relevant at all to the company now or its future price. More importantly none of them was capable of transforming the company like the CNS products are doing right now.

Your sticking with your negative view probably kept you from acting on the obvious ridiculous price we had as recently as August when the price was at $.20 cents. It was then that Nasrat said he was rolling out your beloved opioids one after another over the next 9 months. Anyone looking at the facts as they are and not allowing past events to color their opinion bought more at that time if they had the cash to do so.

Do the math. We have PE in the low 20s without any of the revenue from the approved Methotrexate or the opiods (combined market total over $ 1 billion). Those together will bring in at least $50 million more a year in revenue (assuming a conservative 5% market penetration). That more than justifies the current $0.40 today. Throw in Vyvanse which has a successful BE and no big questions from the FDA. Plus more billion dollar products under development, plus a CEO who says he is growing the company with the goal of M&A in a couple of years.